Abstract | OBJECTIVE: MATERIALS AND METHODS: We retrospectively reviewed clinical records and CT scans of 102 breast cancer patients treated with high-dose chemotherapy and autologous stem cell transplantation. Patients were 26-63 years old (mean, 46 years). The length and width of the thymus gland were measured on serial CT scans obtained before and after treatment. Moderate thymic hyperplasia was recorded if a focal or diffuse increase was seen in the oblong, triangular soft-tissue opacity conforming to the configuration of the normal gland within the anterior mediastinum after therapy. Minimal hyperplasia was recorded when a minimal increase was seen in soft-tissue attenuation conforming to the configuration of the normal bilobed thymus gland within the anterior mediastinum, but no discrete mass was visible. RESULTS: CONCLUSION:
|
Authors | M Hara, H P McAdams, J J Vredenburgh, J E Herndon, E F Patz Jr |
Journal | AJR. American journal of roentgenology
(AJR Am J Roentgenol)
Vol. 173
Issue 5
Pg. 1341-4
(Nov 1999)
ISSN: 0361-803X [Print] United States |
PMID | 10541115
(Publication Type: Journal Article)
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Breast Neoplasms
(drug therapy, pathology)
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Staging
- Thymus Gland
(pathology)
- Thymus Hyperplasia
(chemically induced, pathology)
- Tomography, X-Ray Computed
|